- Grant date: November 2, 2026.
- One new non-executive employee received options for 300,000 shares at $2.01.
Fate Therapeutics awarded 300,000 stock options and 87,000 RSUs to three newly hired non-executive employees as inducement awards. The grants vest over four years and are standard practice for attracting talent.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.